Main > ONCOLOGY (**) > Breast Cancer>HER2+>MET *** > Treatment > JP. D. HER2 MAb-Topoisomerase I> > (3) HER2-low (IHC 1+ or IHC 2+/ISH-

---

- Received CT in MET setting or
- Recurrence.>6 months of completing
Adjuvant Therapy


(3) HER2-low (IHC 1+ or IHC 2+/ISH-'s products
This section has no products